Picture of Decibel Cannabis logo

DB — Decibel Cannabis News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Canada's Decibel Cannabis Q2 revenue rises on international sales growth, lifts FY outlook

Canada's Decibel Cannabis Q2 revenue rises on international sales growth, lifts FY outlook


Overview

  • Canada cannabis producer's Q2 revenue rose 19% yr/yr to record C$35.6 mln

  • Adjusted EBITDA for Q2 rose 24% yr/yr, driven by international sales

  • Company raised full-year 2026 outlook, announced 15:1 share consolidation, eyes normal course issuer bid


Outlook

  • Decibel raises 2026 net revenue outlook to C$132-C$137 mln from C$130-C$135 mln

  • Company lifts 2026 adjusted EBITDA forecast to C$28-C$32 mln from C$27-C$31 mln

  • Decibel expects high single-digit domestic sales growth and strong international sales through 2026


Result Drivers

  • INTERNATIONAL SALES - 72% yr/yr growth in international sales driven by higher demand and volume for flower and extract products

  • DOMESTIC BRAND PERFORMANCE - Domestic sales rose 6% yr/yr, supported by new Standard Issue brand and refreshed General Admission portfolio

  • GROSS MARGIN IMPROVEMENT - Gross margin before fair value adjustments increased to 51% from 47% a year earlier


Company press release: ID:nPn4D4cj6a


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Adjusted EPS

Beat

C$0.01

C$0 (1 Analyst)

Q2 Adjusted Net Income

C$4.24 mln

Q2 Adjusted EBITDA

C$7.80 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the pharmaceuticals peer group is "buy"

  • Wall Street's median 12-month price target for Westleaf Inc is C$0.25, about 117.4% above its August 19 closing price of C$0.12

  • The stock recently traded at 6 times the next 12-month earnings vs. a P/E of 6 three months ago


Reuters Recommended Reads

  • Aug 18 - Curaleaf launches $260 million takeover bid for Aurora Cannabis

  • Aug 20 - Denmark's Stenocare Q2 sales more than doubles on domestic demand


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Decibel Cannabis

See all news